Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil once-daily in men with erectile dysfunction naive to PDE5 inhibitors
2008-004222-17Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Tadalafil once daily with Placebo once daily (2 arms). Primary endpoint: Primary efficacy and safety endpoint. Started Oct 2008; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2008-004222-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004222-17.